This document discusses the early clinical outcomes of introducing a mechanical sphincter augmentation device called LINX for the treatment of GERD. It summarizes the experience from the first 66 patients treated at a single institution. The procedure had a high rate of successful implantation with no complications. Early outcomes showed 83% of patients were off PPIs with high satisfaction rates. Recovery from dysphagia and esophageal clearance issues took longer than typical anti-reflux surgery due to the constant pressure from the device. Careful patient selection and education as well as differentiated post-op management from fundoplication patients were emphasized for successful adoption of this new therapy into clinical practice.